propranolol has been researched along with Neurodegenerative Diseases in 1 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Neurodegenerative Diseases: Hereditary and sporadic conditions which are characterized by progressive nervous system dysfunction. These disorders are often associated with atrophy of the affected central or peripheral nervous system structures.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saengphatrachai, W | 1 |
| Praditukrit, K | 1 |
| Owattanapanich, W | 1 |
| Pitakpatapee, Y | 1 |
| Srivanitchapoom, P | 1 |
1 review available for propranolol and Neurodegenerative Diseases
| Article | Year |
|---|---|
The association between developing Parkinson's disease and β-Adrenoceptor acting agents use: A systematic review and meta-analysis.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Cohort Studies; Humans; Neurodegenerative Dis | 2021 |